Inhibition of hepatitis B virus replication by APOBEC3G.
about
Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodiesAID and APOBECs span the gap between innate and adaptive immunityDeaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminaseAncient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3GHuman APOBEC1 cytidine deaminase edits HBV DNAGenetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivoAdaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificitiesAPOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cellsRole and mechanism of action of the APOBEC3 family of antiretroviral resistance factorsHepatitis B virus replicationHIV-1 Vif and APOBEC3G: multiple roads to one goalTargeting APOBEC3A to the viral nucleoprotein complex confers antiviral activityRestriction of retroviral replication by APOBEC3G/F and TRIM5alphaHIV-1 Vif, APOBEC, and intrinsic immunityA single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivityInhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationIdentification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidationAll APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3GEarly steps of retrovirus replicative cycleFirst Dominique Dormont International Conference on "Host-pathogen interactions in chronic infections - viral and host determinants of HCV, HCMV, and HIV infections"Intracellular immunity to HIV-1: newly defined retroviral battles inside infected cells.APOBEC3G targets human T-cell leukemia virus type 1.APOBEC3G & HTLV-1: inhibition without deaminationThe role of cullin 5-containing ubiquitin ligasesAssociations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review)Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allThe APOBEC3 family of retroelement restriction factorsHepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral interventionThe L60V Variation in Hepatitis B Virus Core Protein Elicits New Epitope-Specific Cytotoxic T Lymphocytes and Enhances Viral ReplicationMolecular mechanisms underlying occult hepatitis B virus infection.TGF-β triggers HBV cccDNA degradation through AID-dependent deaminationReversed functional organization of mouse and human APOBEC3 cytidine deaminase domainsNewly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase HMouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1)Structural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloBNon-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmissionIntrinsic antiviral immunity
P2860
Q21090536-218E2B39-08DB-46AA-864D-92810009552AQ21131084-DFB5A2BB-A6BF-4E10-AF73-C387F3D83E8EQ21131577-1BADE632-FCA6-4BB3-B60B-4709123A1892Q21146408-2CD122C2-2994-4E48-B208-A9922375B463Q21245048-81EFE38F-22BF-4227-993A-528FB6FF63F1Q24305160-CDE25770-2C38-4FAE-B4CE-C7632DEDCA23Q24311896-60541146-0D7B-4F1F-A99E-4561E69D3B43Q24317568-66ACF77C-1DF5-49B7-B239-4B18EA122D3FQ24521469-2AC6AD6E-EE08-4D66-9CAB-67631D9885CBQ24536003-0C3921ED-7648-46C4-83FB-0D5A0D6F7F01Q24537623-0E9395F5-D118-443B-934D-6C07D925363AQ24563894-57BD7654-A96E-4F45-AF9E-C9E4AA05487CQ24564072-0A5FAA09-9C92-4633-B7D2-D8F128C1B0A4Q24565021-DEAC98D6-E2F7-442A-BAE2-CFB774FD9F93Q24630459-170FCDE2-681D-406C-AEB2-6919D0FC9962Q24647833-FB884782-7BEE-41D0-9A4C-D164D41D86DEQ24656551-CB3EDA06-BE9D-4855-8C44-F2D930FBCCE1Q24669993-1F08D26E-3036-4EC8-A5C4-0B034500B9DFQ24672209-CD28C2E9-C4A0-42A4-9905-9C12EA726C92Q24675735-6C5D39E3-2F4D-40C7-835F-BB5B7AFDBEC9Q24681427-A9BE8B08-BED1-4E0D-B7A5-7C06F0655F19Q24792862-32E7BD0C-DDC8-4E88-B28F-B9CD6880AFA8Q24795522-38215B97-22ED-4DF6-BD62-D4496872AE81Q24805644-1D5795A4-084E-414C-B6DB-6C84BAA0640FQ24811566-EEBFDE2B-CD06-4FB1-A29B-9497AA9988E9Q24811603-96FB192B-06DD-4636-9BC8-3842056582DBQ26749274-9D4E7B00-FB6A-4C1F-A726-80819B1EBA69Q26781812-2D2DE171-3B17-4DC8-9A11-57A1AE5CE0B4Q26823568-C298957E-DE35-49D4-BE89-90ED2B804509Q26862780-22DD8D8F-AB0C-4BFA-AD85-919DC7E22F59Q27013849-745D2AA7-781D-4B6A-9BB9-3A6050E33AE8Q27678163-813B23AB-4B11-4A42-A78B-C975AA61F391Q27686923-485A1D50-ADD0-4422-9B72-1D00728A9287Q28119132-F0F3E433-7DCA-4EEA-B1F8-106C23B05DFCQ28266980-D33E78A7-749B-4C3B-B618-9862C8EB9CB2Q28469134-48F41B11-5FC4-45B9-AFFD-FAB65DC4343CQ28510924-E61AD261-7194-4A32-87BA-4F7B8E99D7A8Q28540150-6114C53B-80B3-401C-B4B3-811CD70FD3A2Q28673358-47186DD7-C2A9-4F8F-894B-68FFC0904F27Q28709929-237719CF-0AB4-4F37-B231-10200BC2A394
P2860
Inhibition of hepatitis B virus replication by APOBEC3G.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inhibition of hepatitis B virus replication by APOBEC3G.
@en
type
label
Inhibition of hepatitis B virus replication by APOBEC3G.
@en
prefLabel
Inhibition of hepatitis B virus replication by APOBEC3G.
@en
P2093
P356
P1433
P1476
Inhibition of hepatitis B virus replication by APOBEC3G
@en
P2093
Didier Trono
Priscilla Turelli
Sandrine Vianin
Stephanie Jost
P356
10.1126/SCIENCE.1092066
P407
P577
2004-03-01T00:00:00Z